Fee Schedule – MCAZ

Menu

FAQs

Whatsapp Facebook Twitter Instagram Linkedin Youtube

Search for:

Menu

Home
About Us
Regulatory Functions
Online Services
Information Access Portal
Vaccine Safety
Downloads
Contact Us

Cervia Utete
Comments Off on Circular 12 of 2025 – Fees Schedule
May 9, 2025

Circular 12 of 2025 – Fees Schedule

Circular 12 of 2025 – Fees Schedule1676 DownloadsDownload Now!Size: 914KB

Munya Jaravaza
Comments Off on Circular 19 of 2023: Implementation Plan for Re-Registration of Human Allopathic Medicines _Proposed Fees
July 26, 2023

Circular 19 of 2023: Implementation Plan for Re-Registration of Human Allopathic Medicines _Proposed Fees

Circular 19 of 2023: Implementation Plan for Re-Registration of Human Allopathic Medicines _Proposed Fees2593 DownloadsDownload Now!Size: 708KB

Munya Jaravaza
Comments Off on Circular 19 of 2022 – Fees Schedule
September 19, 2022

Circular 19 of 2022 – Fees Schedule

Circular 19 of 2022 – Fees Schedule2783 DownloadsDownload Now!Size: 645KBPublished: September 19, 2022

Recent Posts

May 14, 2024
Download 2023 Customer Complai...
Read more

May 1, 2024
The Medicines Control A...
Read more

March 26, 2024
2024 Wholesalers Renewa...
Read more

February 23, 2024
2024 Pharmacies Renewal List A...
Read more

May 17, 2023
2022 Customer Complaints Trend...
Read more

May 16, 2023
MCAZ’s Microbiology Lab...
Read more

QUICK LINKS

Menu

Home
Sign in to Online Services
Registered & Approved Medicines
Medicines Information Bulletin
Go to Downloads
Apply for a vacancy

FACEBOOK FEED

Cover for Medicines Control Authority of Zimbabwe

Medicines Control Authority of Zimbabwe

5 days ago

Substandard and falsified (SF) medicines threaten millions of people worldwide.Report to the MCAZ, any suspected SF products you may encounter. The Authority urges the public to access registered medicines from licenced persons and premises. #medsafety ... See MoreSee Less

View on Facebook

· Share

Share on Facebook Share on Twitter Share on Linked In Share by Email

Medicines Control Authority of Zimbabwe

6 days ago

Today, the Authority joins the global community in commemorating #WorldAIDSDay Day 2025.MCAZ reaffirm its commitment to protecting public health by ensuring access to safe, effective, and good-quality medicines and medical devices.Last month, the Authority approved and registered #lenacapavir, an innovative long-acting medicine for pre-exposure prophylaxis (PrEP) to help prevent HIV-1 infection—supporting national and global efforts in the fight against HIV and AIDS.Together, we can strengthen the response, save lives, and build a healthier future.#WorldAIDSDay ... See MoreSee Less

View on Facebook

· Share

Share on Facebook Share on Twitter Share on Linked In Share by Email

Medicines Control Authority of Zimbabwe is with Zambia Medicines Regulatory Authority - ZAMRA and 6 others.

2 weeks ago

🚨 ANNOUNCEMENT 🔊 The Medicines Control Authority of Zimbabwe (MCAZ) announces the expedited approval of #Lenacapavir, an innovative long-acting medicine for pre-exposure prophylaxis (PrEP) to prevent HIV-1 infection. The application, submitted by Gilead on the 29th of October 2025, underwent a rigorous evaluation and was finalised in twenty-three (23) days, demonstrating the Authority’s commitment to ensuring timely access to essential, life-saving health products.The registration of #Lenacapavir marks a significant advancement in Zimbabwe’s HIV prevention strategy. By providing a long-acting alternative to daily oral #PrEP, this product has the potential to improve adherence and expand prevention options for populations most vulnerable to HIV infection.🔴 Details: portal.mcaz.co.zw/wp-content/uploads/2025/11/MEDIA-RELEASE-MCAZ-Registers-LENACAPAVIR_RvdDK-1ZAM.pdf ... See MoreSee Less

View on Facebook

· Share

Share on Facebook Share on Twitter Share on Linked In Share by Email

Medicines Control Authority of Zimbabwe

2 weeks ago

MCAZ at the Zimbabwe Antimicrobial Resistance (AMR) Conference 202519–20 November | HICCQuality-assured medicines are essential in protecting public health and preventing the spread of antimicrobial resistance (AMR).At this year’s conference, MCAZ showcased its (handheld) portable field detection technologies that help rapidly identify substandard and falsified medicines in both human and veterinary sectors. These innovations strengthen surveillance beyond the laboratory and support timely regulatory action.The Authority also had the opportunity to demonstrate the devices to the Minister of Ministry of Health and Child Care, highlighting the importance of technology and innovation in the fight against antimicrobial resistance.Poor-quality medicines fuel AMR. Through strong surveillance and a One Health approach, MCAZ continues to protect people, animals, and the environment.#AntimicrobialResistanceAwareness ... See MoreSee Less

View on Facebook

· Share

Share on Facebook Share on Twitter Share on Linked In Share by Email

X FEED

Medicines Control Authority of Zimbabwe Follow

MCAZ is responsible for protecting public and animal health by ensuring safety of accessible medicines and allied substances. mcaz@mcaz.co.zw. +263718855934

Medicines Control Authority of Zimbabwe @mcazofficial ·

2 Dec

Substandard and falsified (SF) medicines threaten millions of people worldwide.
Report to the MCAZ, any suspected SF products you may encounter. The Authority urges the public to access registered medicines from licenced persons and premises.

Reply on Twitter 1995739467030610125 Retweet on Twitter 1995739467030610125 1 Like on Twitter 1995739467030610125 2 Twitter 1995739467030610125

Medicines Control Authority of Zimbabwe @mcazofficial ·

1 Dec

MCAZ commemorates #WorldAIDSDay and reaffirms its commitment to ensuring access to safe, effective medicines. This year we highlight the recent expedited registration of Lenacapavir, a long-acting PrEP option supporting HIV prevention.
#WorldAIDSDay2025

Reply on Twitter 1995477725566345482 Retweet on Twitter 1995477725566345482 1 Like on Twitter 1995477725566345482 3 Twitter 1995477725566345482

Medicines Control Authority of Zimbabwe @mcazofficial ·

24 Nov

🚨 ANNOUNCEMENT

🔊 The Medicines Control Authority of Zimbabwe (MCAZ) announces the expedited approval of #Lenacapavir, an innovative long-acting medicine for pre-exposure prophylaxis (PrEP) to prevent HIV-1 infection.

🔴 Details: https://portal.mcaz.co.zw/wp-content/uploads/2025/11/MEDIA-RELEASE-MCAZ-Registers-LENACAPAVIR_RvdDK-1ZAM.pdf

Reply on Twitter 1992903961813430442 Retweet on Twitter 1992903961813430442 2 Like on Twitter 1992903961813430442 7 Twitter 1992903961813430442

Retweet on Twitter Medicines Control Authority of Zimbabwe Retweeted

𝐇𝐞𝐚𝐥𝐭𝐡 𝐓𝐢𝐦𝐞𝐬 @healthtimeszim ·

22 Nov

🚨 Big news: Zimbabwe’s Medicines Control Authority (MCAZ) has fast-tracked approval of #Lenacapavir , a long-acting HIV PrEP! This injectable could transform HIV prevention.
Read more: https://healthtimes.co.zw/zimbabwes-medicines-regulatory-body-registers-lencapavir/ @GileadSciences @GileadHIV @MoHCCZim @naczim @MCAZofficial #HIV

Reply on Twitter 1992212618824597796 Retweet on Twitter 1992212618824597796 10 Like on Twitter 1992212618824597796 15 Twitter 1992212618824597796

Load More

CONTACT US

106 Baines Ave, Harare, Zimbabwe
+263-242-736981/5;
708255; 792165;

+263 772-145-191/2/3

WhatsApp : 0718 855 934

Toll Free Econet : 08080641

Toll Free TelOne : 08004507

mcaz@mcaz.co.zw

MCAZ - Protecting your right to quality medicines and medical devices

Copyright © 2025 MCAZ | Site Done by MCAZ